High-density polyethylene (HDPE)-incorporated boron carbide and boric acid nanoparticles as a nanoshield of photoneutrons from medical linear accelerators.

PURPOSE: The current study aimed to investigate boron carbide and boric acid nanoparticles (NPs) as absorbents for thermal neutrons and high-density polyethylene (HDPE) as a substrate and neutron moderator for fast neutrons. The goal was to assess the performance of boron carbide and boric acid NPs based on HDPE as a nanoshield of photoneutrons from medical linear accelerators. MATERIALS AND METHODS: This study was conducted in two parts of simulation and practice. The Monte Carlo (MC) simulation involved modeling and verification of the single-layer, double-layer, and combined nanoshields by selecting nanomaterials and substrates and, finally, calculating the macroscopic cross-sections. The practical part involved manufacturing nanoshields based on the simulation results and evaluating the manufactured nanocomposites via experimental measurements. RESULTS: MC simulation results with an uncertainty of less than 1% showed that for the monolayer samples, the best result belonged to boron carbide at a concentration of 10% and a macroscopic cross-section of 0.933 cm-1. At a concentration of 20%, the highest value among the double-layer samples was 0.936 cm-1 and for the combined samples, this value was 0.928 cm-1. Boron carbide single-layer nanocomposites at a 10% concentration, as well as the bilayer nanoshield of 10% boron carbide and 20% boric acid performed well; however, the best performance belonged to the nanoshield with a macroscopic cross-section of 0.960 and the combination containing 5% boron carbide and 10% boric acid. CONCLUSIONS: The research suggests that utilizing boron carbide and boric acid nanoshields in combination with HDPE holds promise as a viable approach to protecting from the photoneutrons. Further exploration of these nanocomposite shields and their practical applications is warranted, with the potential to yield significant advancements in radiation therapy safety and efficacy.

Assessment of the toxicity of weathered petroleum hydrocarbon impacted soils to native plants from a site in the Canadian Subarctic.

Remedial guidelines for petroleum hydrocarbons (PHCs) in soil aid in the mitigation of risks to human health and the environmental. However, some remediation guidelines may overestimate the potential for adverse effects to native plant species, contributing to unnecessary remedial efforts in attempts to meet the guidelines. At sites where PHC-contaminated soils undergo weathering, some PHCs may persist but with decreased bioavailability to organisms. In this study, the toxicity of both coarse and fine-grained subarctic soils, contaminated with weathered PHCs were assessed using five native plant species (Picea mariana, Achillea millefolium, Alnus viridis, Elymus trachycaulus and Salix bebbiana). Soil toxicity tests were conducted in a growth chamber with parameters set to simulate the site's subarctic climate conditions. Reference toxicant tests using boric acid were conducted to provide confidence in the interpretation of the results for the PHC-contaminated soils, and also provide new information on the sensitivities of the four boreal species to boric acid. All plants exhibited reduced growth and germination rates as boric acid concentrations increased. Despite exceeding the Canada-wide standard guidelines for Fraction 3 PHCs, field-collected contaminated soils had no significant negative impacts on the growth (i.e., length, dry weight and emergence) of any of the plant species tested.

Assessment of consumer exposure to boron in cleaning products: a case study of Canada.

Boron is an essential mineral for plants, and as such, is a normal dietary constituent for humans. Humans may be naturally exposed to boron through food and drinking water, or via anthropogenic sources such as consumer products. The World Health Organisation established an acceptable safe range of population mean intakes for boron of 1-13 mg/day. Most studies of dietary boron intake show a range of 1-2 mg/day. Consumer products have been estimated to contribute a geometric mean daily intake of 0.1 mg to total boron exposure; however, there are few published surveys of consumer exposure to boron from use of cleaning products. The Government of Canada published a draft screening assessment report of boric acid, its salts and precursors that included estimates of consumer exposure to boron found as ingredients in consumer products. The manufacturers of consumer cleaning products conducted a survey of boron content of current products and estimated exposure using the publicly available exposure tool ConsExpo Web. Dermal exposures to boron during cleaning product use were estimated to result in annual internal exposures ranging from ≪0.001 to 0.36 µg/kg bw/day based on dermal absorption of 0.5%. Using a conservative point of departure for hazard assessment (2,900 µg boron/kg bw/day), estimated margins of exposure for dermal exposures to boron from cleaning product use range from 8,056 to >1,000,000. This work demonstrates that exposure to boron from cleaning product use is very low and essentially insignificant when compared to other (e.g. dietary) sources of boron intake by Canadian consumers.

Simple and low cost alternative method for detecting photoneutrons produced in some radiotherapy treatments using SSNTDs.

A simple and low cost alternative which is able to identify thermal and fast neutrons in a clinical environment of radiotherapy is presented. CR-39 and LR-115 Solid State Nuclear Track Detectors (SSNTDs) were used, estimating their viability. In order to register alpha tracks due to thermal neutrons, natural boric acid tablets were placed in close contact to the detector, whereas in order to detect epithermal neutrons, some were additionally covered in a thin cadmium layer. Different configurations were assembled, changing the position of the converter with respect to the detector and the incident neutron fluence, which was evaluated in different positions of a radiotherapy table. The contribution due to environmental 222Rn and its daughters to the track density registered by the detector during the measurements was found to be negligible. It is concluded that the designed experimental set up constitutes a trustworthy and affordable method to carry out neutron measurements with the recommended configurations provided for the CR-39 detector, and not with LR-115.

Radiation Chemical Yield of Hydroxyl Radicals for Accelerator-based Boron Neutron Capture Therapy: Dose Assessment of 10B(n,α)7Li Reaction Using Coumarin-3-Carboxilic Solution.

Evaluation of the characteristics of accelerator-based thermal neutron fields is recognized as an important issue when discussing the effectiveness of boron neutron capture therapy (BNCT). In this study, we propose that the radiation chemical yield (G value) of hydroxyl radicals (Goh•) can be considered a universal parameter for the description of the accelerator-based thermal neutron field. The Goh• of the 10B(n,α)7Li reaction was quantitatively evaluated using an aqueous coumarin-3-carboxylic acid (3CCA) solution, and was discriminated from that of contaminations (i.e., γ rays and fast neutrons). The Goh• of the 10B(n,α)7Li reaction was 0.107 ± 0.004 OH•/100 eV, which is almost equivalent to that exposed to α particles with an energy of 6.0 MeV. Since the Goh• of γ rays from a 60Co source is 2.03 ± 0.05 OH•/100 eV, this lower value suggests that indirect action by the 10B(n,α)7Li reaction is not dominant in BNCT. However, our results indicate that one can assess the 60Co equivalent dose of the 10B(n,α)7Li reaction in water from the Goh• derived using aqueous 3CCA solution in the accelerator-based thermal neutron field.

Feasibility of a Supporting-Salt-Free Nonaqueous Redox Flow Battery Utilizing Ionic Active Materials.

Nonaqueous redox flow batteries (NAqRFBs) are promising devices for grid-scale energy storage, but high projected prices could limit commercial prospects. One route to reduced prices is to minimize or eliminate the expensive supporting salts typically employed in NAqRFBs. Herein, the feasibility of a flow cell operating in the absence of supporting salt by utilizing ionic active species is demonstrated. These ionic species have high conductivities in acetonitrile (12-19 mS cm-1 ) and cycle at 20 mA cm-2 with energy efficiencies (>75 %) comparable to those of state-of-the-art NAqRFBs employing high concentrations of supporting salt. A chemistry-agnostic techno-economic analysis highlights the possible cost savings of minimizing salt content in a NAqRFB. This work offers the first demonstration of a NAqRFB operating without supporting salt. The associated design principles can guide the development of future active species and could make NAqRFBs competitive with their aqueous counterparts.

Efficient boron abstraction using honeycomb-like porous magnetic hybrids: Assessment of techno-economic recovery of boric acid.

Porous magnetic hybrids were synthesized and functionalized with glycidol to produce boron-selective adsorbent. The magnetic hybrid (MH) comparatively out-performed the existing expensive adsorbents. MH had a saturation magnetisation of 63.48 emu/g and average pore diameter ranging from meso to macropores. The magnetic hybrids showed excellent selectivity towards boron and resulted in 79-93% boron removal even in the presence of competing metal ions (Na+ and Cr2+). Experiments were performed in a column system, and breakthrough time was observed to increase with bed depths and decreased with flow rates. The batch experiments revealed that 60 min was enough to achieve equilibrium, and the level of boron sorption was 108.5 mg/g from a synthetic solution. Several adsorption-desorption cycles were performed using a simple acid-water treatment and evaluated using various kinetic models. The spent adsorbents could be separated easily from the mixture by an external magnetic field. The cost-benefit analysis was performed for the treatment of 72 m3/year boron effluent, including five years straight line depreciation charges of equipment. The net profit and standard percentage confirmed that the recovery process is economically feasible.

Is Boric Acid Toxic to Reproduction in Humans? Assessment of the Animal Reproductive Toxicity Data and Epidemiological Study Results.

Boric acid and sodium borates are classified as toxic to reproduction in the CLP Regulation under "Category 1B" with the hazard statement of "H360FD". This classification is based on the reprotoxic effects of boric acid and sodium borates in animal experiments at high doses. However, boron mediated reprotoxic effects have not been proven in epidemiological studies so far. The epidemiological study performed in Bandirma boric acid production plant is the most comprehensive published study in this field with 204 voluntarily participated male workers. Sperm quality parameters (sperm morphology, concentration and motility parameters), FSH, LH and testosterone levels were determined in all participated employees as the reproductive toxicity biomarkers of males. However, boron mediated unfavorable effects on reproduction in male workers have not been determined even in the workers under very high daily boron exposure (0.21 mg B/kg-bw/day) conditions. The NOAEL for rat reproductive toxicity is equivalent to a blood boron level of 2020 ng/g. This level is higher than the mean blood boron concentration (223.89 ± 69.49 ng/g) of the high exposure group workers in Bandirma boric acid production plant (Turkey) by a factor of 9. Accordingly, classifying boric acid and sodium borates under "Category 1B" as "presumed reproductive human toxicant in the CLP regulation seems scientifically not reasonable. The results of the epidemiological studies (including the study performed in China) support for a down-classification of boric acid from the category 1B, H360FD to category 2, H361d, (suspected of damaging the unborn child).

EPR/alanine pellets with low Gd content for neutron dosimetry.

This paper reports on results obtained by electron paramagnetic resonance (EPR) measurements and Monte Carlo (MC) simulation on a blend of alanine added with low content of gadolinium oxide (5 % by weight) to improve the sensitivity to thermal neutron without excessively affecting tissue equivalence. The sensitivity is enhanced by this doping procedure of more an order of magnitude. The results are compared with those obtained with the addition of boric acid (50 % by weight) where boron is in its natural isotopic composition in order to produce low-cost EPR dosemeters. The gadolinium addition influences neutron sensitivity more than the boron addition. The presence of additives does not substantially change the fading of the EPR signal induced by neutrons. The MC simulations agree the experimental results in case of gadolinium addition.

Evaluation of commercial boric acid containing vials for urine culture: low risk of contamination and cost effectiveness considerations.

BACKGROUND: Urine culture is a gold standard in the diagnosis of urinary tract infection. Clean catch midstream urine collection and prompt transportation is essential for appropriate diagnosis. Improper collection and delay in transportation leads to diagnostic dilemma. In developing countries, higher ambient temperatures further complicate the scenario. Here, we have evaluated the role of boric acid as a preservative for urine samples prior to culture in female patients attending outpatient department at our center. MATERIALS AND METHOD: Consecutive 104 urine samples were cultured simultaneously in plain uricol (Control-C) and boric acid containing tubes from Becton Dickinson urine culture kit (Boric acid group-BA). RESULTS: In the real-time evaluation, we found that in almost 57% (59/104) of the urine samples tested, it was more effective in maintaining the number of the organisms as compared to samples in the container without any preservative. Our in vitro study of simulated urine cultures revealed that urine samples could be kept up to 12 h before culture in the preservative without any inhibitory effect of boric acid. Though the use of boric acid kit may marginally increase the initial cost but has indirect effects like preventing delays in treatment and avoidance of false prescription of antibiotics. If the man-hours spent on repeat investigations are also taken into consideration, then the economic cost borne by the laboratory would also decrease manifold with the use of these containers.

The determination of uric acid in urine--forgotten problems rediscovered in an external quality assessment scheme.

This article mainly describes the effects of boric acid and borates often used as bacteriostatic agents in urine collection for microbiological examination, on the results obtained in the measurement of uric acid in urine using the uricase [EC.1.7.3.3] method. The bias in results is not unidirectional, the spread of results being much larger than in urine samples not containing borate. Borate ions are also known to inhibit other enzymes such as urease [EC 3.5.1.5]. Results are presented from six national external quality assessment (EQA) surveys carried out in 2007 by INSTAND in Düsseldorf, Germany. Whereas the performance--expressed as the success rate--in samples not containing borate was acceptable (between 90 and 95%), this was not the case where borate was present (success rate 68-72%). The results also showed systematic differences for different kits which were partly due to differences in standardisation/calibration and partly due to interference by borate. Some effects of ascorbic acid and sodium azide on the determination of uric acid in urine using uricase have also been presented. The results show that care must be taken in the preanalytical phase, especially in referral laboratories, in order to prevent wrong interpretation of results due to methodological failure in the unknown presence of borate ions.

Assessment of the chemical changes induced in human melanoma cells by boric acid treatment using infrared imaging.

Boron is found in everyday foods and drinking water in trace quantities. Boron exists as boric acid (BA) within plants and animals, where low levels have been linked to cancer incidence. However, this correlation is not well characterized. In this study, we examined the chemical and morphological effects of BA on human skin melanoma cells (SK-MEL28) using Fourier Transform InfraRed Imaging (FTIRI) with a Focal Plane Array (FPA) detector. Cells were grown under concentrations of BA ranging from 0 to 50 mM. Cell viability was determined after 1, 2, 3, 5, 7 and 10 days using trypan blue staining. With FTIRI, images of approximately twenty cells per time point per condition were collected. Principal components analysis (PCA) was used to evaluate changes in cell composition, with particular focus on the lipid, protein, and nucleic acid spectral components. Results from trypan blue staining revealed decreased cell viability as BA concentration increased. FTIRI data indicated that the protein and lipid contents (as indicated by the lipid/protein ratio) did not undergo substantial changes due to BA treatment. In contrast, the nucleic acid/protein ratio significantly decreased with BA treatment. PCA results showed an increase in beta-sheet protein at higher concentrations of BA (12.5, 25, and 50 mM). Together, these results suggest that high concentrations of BA have an anti-proliferative effect and show signs consistent with apoptosis.

Uso ocular de água boricada: condições de manuseio e ocorrência de contaminação / Use conditions of boric acid solution in the eye: handling and occurrence of contamination

OBJETIVOS: Avaliar as condições de uso de água boricada e verificar a contaminação dos frascos e seu conteúdo. MÉTODOS: Foram selecionados, por critério de conveniência, quarenta e dois pacientes, usuários de água boricada, que compareceram ao Pronto-Socorro de Oftalmologia do Hospital São Paulo, em fevereiro e março de 2003. Foi colhido material para cultura do saco conjuntival, da superfície interna da borda do frasco, da superfície interna da tampa, além de 1 ml de solução do frasco. RESULTADOS: Dos 42 recipientes de água boricada, 17 (40,5 por cento) apresentavam contaminação, sendo 1 (2,4 por cento) no conteúdo liquido, 17 (40,5 por cento) na parte interna da tampa e 6 (14,3 por cento) na parte interna da borda do frasco. Dos 17 frascos contaminados, 10 (58,8 por cento) tiveram suas tampas manuseadas de maneira inadequada e 13 (76,5 por cento) frascos já haviam sido usados em outras ocasiões. Os microrganismos mais encontrados nas tampas e bordas foram Staphylococcus sp (69,6 por cento) e bacilos Gram-positivos (26,1 por cento). Dezesseis (38,1 por cento) frascos foram abertos há mais de um mês e, destes, 5 (31,3 por cento) apresentaram contaminação. A instrução de uso nos rótulos dos frascos era inconsistente. A utilização de água boricada foi por conta própria, por indicação de amigos ou parentes em 26 (61,9 por cento) casos; indicação de farmacêuticos em 8 (19,0 por cento); de oftalmologistas em 5 (11,9 por cento) e de clínicos gerais em 3 (7,1 por cento). CONCLUSÃO: A indicação de uso tópico oftálmico de água boricada foi feita, na maioria, por leigos. Os frascos, em geral, eram manipulados de maneira inadequada, apresentando contaminação em uma proporção de casos muito maior do que a contaminação do líquido. Essa porcentagem menor de contaminação do conteúdo provavelmente está associada às características anti-sépticas do produto.

PURPOSE: To evaluate use conditions and detect contamination in bottles of boric acid solution. METHODS: A convenience sample of 42 recruited patients using boric acid solution came to the Ophthalmology Emergency Room of the São Paulo Hospital from February to March of 2003. Cultures were taken from material of the conjunctival sac, inner surface of bottle edge, inner part of cap and from 1 ml of boric acid solution of each bottle. RESULTS: Of the 42 boric acid solution bottles, 17 (40.5 percent) showed contamination: 1 (2.4 percent) in the solution, 17 (40.5 percent) in the inner cap and 6 (14.3 percent) in the inner part of the bottle edge. Of the 17 contaminated bottles, 10 (58.8 percent) were handled inappropriately and 13 (76.5 percent) of the bottles were not discharged after first use. The most common microorganisms found in the caps and edges of the bottles were Staphylococcus sp (69.6 percent), followed by Gram-positive bacillus (26.1 percent). Sixteen bottles (38.1 percent) had been opened more than a month ago and 5 (31.3 percent) of those showed contamination. The boric acid solution bottle directions shown on the labels were incomplete and not clear. The use of boric acid solution was on recommendation of their own, friends or relatives in 26 (61.9 percent) cases; pharmacists in 8 (19.0 percent) cases, ophthalmologists in 5 (11.9 percent) cases and general practitioners in 3 (7.1 percent) cases. CONCLUSION: In most cases, the topic use of boric acid solution was recommended by non-physicians. The bottles, in general, were handled inappropriately, and hence presented a much higher level of contamination that did the boric acid solution inside. The lower level of contamination in the solution is possibly associated with the anti-septic characteristics of the boric acid solution.

[Vulvovaginal candidiasis: a therapeutic approach]. / Vulvovaginiti da candida. Approccio terapeutico.

The vulvovaginal candidiasis represents, after the bacterial vaginosis, the most frequent cause of vaginal affection. It is esteemed that around the 75% of the women of reproductive age suffered from an episode of vulvovaginitis from candida and 40-45% have had more episodes, of which 10-20% in complicated form. The kind of candida more frequently isolated in the vagina of symptomatic women is the Candida albicans: in the 10-20% of the cases the agent is present in absence of symptomatology, and we can almost consider it a saprophytic. On the other hand, always with greater frequency fetterses can be isolated of not albicans Candida, particularly the tropicalis and the glabrata kind, usually resistant to the common therapies. The classification of the vulvovaginal candidiasis proposed by Sobel, and by now universally approved, foresees 2 clinical forms of vulvovaginal candidiasis, the vulvovaginitis from not complicated candida (VVC) and the vulvovaginitis from complicated candida (VVCC): different for pathogenesis, elapsed clinical, symptomatology and frequency. They have to be considered in the substance 2 different nosological entities, and they request a diagnostic approach and a well different therapeutic appointment. In this study we will shortly reassume the principal characteristics of it, detaining us on the most recent acquisitions in theme of therapy. The base medicines of ac. boric, to parity of effectiveness, seem to introduce the most contained cost and the best compliance, and they offer him to a complementary use or, in some cases, alternative to the more you consolidate therapies with azoli.

Toxicity of boron to rainbow trout: a weight-of-the-evidence assessment.

From the large data set available on the toxicity of boron to aquatic organisms, the toxicity of boron to the early life stages of rainbow trout (Oncorhyncus mykiss) is the seminal issue relative to setting water quality criteria and effluent standards. Issues associated with the early life stage studies are the flat concentration-response curve, the low threshold of toxicity, and teratogenic effects observed. Recent laboratory and field studies offer new experimental data that make a weight-of-the-evidence assessment timely. In a re-examination of the effect of boron on the embryo-larval stage in rainbow trout and zebrafish, adverse effects due to boron deficiency are observed which decrease with increasing dose. It was found that low concentrations of boron stimulate embryonic growth in rainbow trout and increase the viability and survival of embryonic zebrafish. As boron concentration is further increased, the dose-response curve becomes flat as homeostatic processes are active; this is followed at higher doses by a new adverse response that increases with increasing dose. As a result, the dose-response relationship is U shaped, consistent with the characteristic shape of an essential micronutrient. Thus, effects originally reported to be toxicity at low exposures rather may be due to boron deficiency. Water analyses in trout hatcheries and field studies in wild trout streams add additional information on the toxicity of boron to trout. Of particular note is a controlled field study carried out in the Firehole River in Yellowstone Park (WY, USA), where trout populations survive and reproduction successfully occurs in natural water containing boron concentrations up to and in some cases greater than 1.0 mg B/L. Teratogenic effects due to boron exposure were not observed in any of these more recent studies.

Advances in understanding mechanisms of toxicity and implications for risk assessment.

Knowledge of mechanism of action of a toxicant can greatly improve the accuracy of risk estimation by replacing with data the many default assumptions of risk assessment. Results from studies on comparative pharmacokinetics, metabolism, cell biology, and molecular biology have been successfully applied to problems of interspecies extrapolation, interindividual differences in susceptibility, and the relevance of high-dose findings for low-dose risk estimation. Examples are provided. Extremely rapid progress in understanding the molecular control of embryonic pattern formation and organogenesis has the potential to significantly improve the accuracy of risk assessment, especially by providing a sounder basis for characterizing interspecies differences, individual susceptibility, and multifactorial (gene-environment) etiologies of abnormal development. However, it will be necessary to quantitate toxicant-induced changes at the molecular level and to determine the level of change needed to perturb higher levels of biological organization at which adverse effects are manifested. It will also be important for risk assessment methodology to evolve so that it can better and more routinely accommodate mechanistic information. There is great potential for the recent and coming advances in knowledge of the molecular and cellular basis of abnormal development to be applied to risk assessment. Consideration should be given to shifting some of the resources now allocated to hazard screening to investigating the mechanisms of chemically induced abnormal development.

An assessment of boric acid and borax using the IEHR Evaluative Process for Assessing Human Developmental and Reproductive Toxicity of Agents. Expert Scientific Committee.

BACKGROUND: Boron is a ubiquitous element widely distributed in nature in the form of borates at low concentrations in soils and rocks. Boron is released from these minerals by the natural weathering processes in the form of boric acid, which is water soluble and biologically available. High levels of boric acid are naturally found in sea water. Boric acid and borax are used in the greatest quantities and represent the major boron chemical exposures to humans and the environment. The principal use of boric acid and borax is in the manufacture of various types of glass products that do not result in exposure to the consumer. Boric acid and borax are also found in an array of consumer goods including fireproofing for fabrics and wood, insecticides, and in many cosmetics and personal care products as well. Boron may be an essential element for higher animals including humans. HUMAN EXPOSURE: Boric acid and borax are considered to be completely absorbed by the oral route of exposure. Absorption through intact skin is considered negligible, although absorption can occur through denuded or irritated skin. Boron levels in the body do not persist upon cessation of exposure. People may be exposed to boron through three primary sources: 1) consumption of private, municipal, or commercial (bottled) sources of drinking water; 2) dietary consumption of crops and other foodstuffs (including dietary supplements for body building); and 3) inhalation of boron compounds during their mining, manufacturing, and other industrial processing. While boron has been detected in 81.8% of the municipal water systems, it is a minor source of boron in most parts of the U.S. The mean boron concentration is reported as 0.2 mg B/L. However, residents of California and other western states with boron-rich geologic deposits may be regularly exposed to higher levels in drinking water. Individuals who drink bottled mineral water may also increase their exposure to boron. An EPA health advisory, recommends boron concentrations in drinking water not exceed 0.6 mg B/L [0.06 mM B] over a lifetime of exposure. Dietary exposure to boron for an adult typically ranges from ranges from 0.25 to 3.1 mg B/d with an average of 1.5 mg B/d. The high end of the exposure range, 3.1 mg B/d, was selected by the Expert Committee as best estimate of exposure. It should be noted that a diet high in fruits, vegetables, grains, legumes, and other food stuffs with high boron contents may lead to daily exposures as high as 10 mg B/d from diet alone. Some body building supplements contain boron at levels ranging from 1.5 to 10 mg B, with a median of 4 mg B. Use of the supplements containing the median concentration of boron could equal the daily intake an individual receives from diet and drinking water combined. Adults in the U.S. at the high end of the food exposure range may typically ingest up to 3.5 mg B/d, or a daily dose of 0.005 mmol B/kg b.wt., through exposure from diet (3.1 mg B/d) and drinking water (0.4 mg B/d). Individuals who also use body-building supplements may have a total daily boron intake of 7.5 mg B resulting in a daily dose of 0.01 mmol B/kg b.wt./d. Occupational exposure to boron is mainly through inhalation of borate containing dust during mining and manufacturing processes. Current occupational exposures to boron are reported to result in a daily dose of < 0.0001 to 0.2 mmol B/kg b.wt./d. Current U.S. OSHA permissible exposure limit (PEL) for sodium tetraborates is 10 mg/m3, and the California Occupational Safety and Health Administration PEL is 5 mg/m3. An exposure of 5 mg B/m3 translates to approximately 0.01 mmol B/kg b.wt./d that, coincidentally, is the same as exposure levels associated with combined municipal drinking water, diet, and body building supplement consumption. Infants may receive exposures to boric acid when it is used as a household insecticide for cockroach control. Exposure from boric acid-containing cosmetic and personal care products applie

Hazard assessment of boric acid in toys.

Boric acid (H3BO3) has been used in a wide variety of applications--medication, pesticides, and household products. Reports of child poisoning by H3BO3 were common in the clinical literature before 1975. However, a decline in its use as a bacteriostatic agent coupled with increased regulatory control has almost eliminated poisonings by accidental ingestion. Schedule I (Part I, Item 8) of the Hazardous Products Act of Canada, proclaimed in the late 1960s, followed in the wake of concerns about accidental poisoning and prohibits its use in toys. Since that time, scientific knowledge has increased and has led to a reevaluation of the hazard associated with H3BO3. A maximum tolerated dose (MTD) was sought for children in the most susceptible age range, with a view to determine a maximum acceptable concentration (MAC) in toys. The effects of H3BO3 in a variety of exposure scenarios were evaluated. Precedence was given to clinical data in humans, particularly children, since there is no suitable animal model of boric acid intoxication. An extensive search of the pediatric literature was conducted to find a no-observed-adverse-effect level (NOAEL) or a lowest-observed-adverse-effect level (LOAEL). An analysis of the pivotal study to the present assessment resulted in the application of an uncertainty factor of 100 to account for variations in sensitivity among children and for the use of a LOAEL. Based on a pediatric LOAEL of 300 mg/kg body wt, we derived a MTD of 3 mg H3BO3/ kg body wt and a MAC of 9.1 mg H3BO3/g of toy. These results compared favorably with calculations from other human and animal NOAELs/LOAELs.

Noncancer risk assessment: reproductive toxicology.

In summary, the concerns that environmental and other agents are causing adverse effects on reproductive function in humans are real, although the risk is not necessarily well characterized. The range of concerns for the types of effect that agents might have on reproduction span the full range of reproductive events. There is a fairly high background of reproductive disease in humans which decreases the sensitivity for identifying agents that have a subtle, but adverse, effect on reproductive performance of humans. Because our animal studies identify a large number of agents that cause some adverse reproductive effect at the dose levels tested, the concern is raised about the oversensitivity of animal models for predicting adverse effects in humans. Until we better understand the biology underlying the reproductive process of humans and animals, it will be difficult to make animal studies more specific in their predictiveness. Continued research to better understand the biology of reproduction in humans and animals should help to identify the types of data generated in animals that are most predictive of an adverse effect in humans.

A human health risk assessment of boron (boric acid and borax) in drinking water.

A human health risk assessment was conducted to derive an appropriate safe exposure level in drinking water of inorganic boron-containing compounds (boric acid and borax). Several regulatory agencies have set or plan to set drinking water guidelines or standards for boron (B). Recent publication of reproductive and developmental toxicity studies by the National Toxicology Program prompted this risk assessment, along with the understanding that boron may be nutritionally essential. A rat developmental toxicity study with a NOAEL of 9.6 mg B/kg/day was selected as the pivotal study on which to base this risk assessment, since it represents the most sensitive endpoint of toxicity. A detailed evaluation of these and other studies allowed modifications of the default values for uncertainty factors to account for the pharmacokinetic similarities among species, the lack of metabolism of inorganic boron-containing compounds, the similarity of the toxicity profile across species, the quality of the toxicological database, and other factors according to the approach described by Renwick previously. Benchmark dose calculations were performed, and the results were in close agreement with the NOAEL selected for this risk assessment. The Reference Dose was calculated to be 0.3 mg B/kg/day, resulting in an acceptable daily intake of 18 mg B/day. Considering that the U.S. average dietary intake of boron is 1.5 mg B/day, 16.5 mg B/day could be available for drinking water or other exposures, if any. A preliminary review of boron data in the National Inorganic Radionuclide Survey by the EPA indicates the median boron level in U.S. drinking water supplies to be 0.031 mg B/liter, and most exposures are less than 2.44 mg B/liter (99th percentile). It is concluded that boron in U.S. drinking water would not be expected to pose any health risk to the public.